MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Free water imaging of the cholinergic forebrain in body vs. brain-first Parkinson’s disease subtypes

    S. Roytman, Y. Ota, T. Brown, P. Scott, R. Albin, P. Kanel, N. Bohnen (Ann Arbor, USA)

    Objective: To investigate the relationship between basal forebrain (BF) neurodegeneration and cholinergic system in body vs brain-first Parkinson’s disease (PD) subtypes. Background: Free water imaging…
  • 2023 International Congress

    Clinical features and phenoconversion risk in women with isolated REM sleep behavior disorder

    C. Alexandres, S. Mccarter, G. Tabatabai, L. Leclair-Visonneau, J. Feemster, T. Gossard, P. Timm, D. Sandness, J. Jagielski, E. Strainis, D. Carvalho, M. Junna, M. Lipford, J. Moore, M. Tippmann-Peikert, M. Silber, B. Boeve, E. ST. Louis (Rochester, USA)

    Objective: To determine features predictive of differential phenoconversion rates in isolated REM sleep Behavior Disorder (iRBD) to a defined neurodegenerative disease (NDD). Background: iRBD is…
  • 2023 International Congress

    Analysis of a wearable sensor, STAT-on®, to detect motor complications in patients with Parkinson´s disease (PDp)

    J. Parra Serrano, MI. Morales Casado, N. Lopez Ariztegui (Toledo, Spain)

    Objective: Analysis of the use of a personalized monitoring device, STAT-on®, to detect motor complications in PDp and its impact on the therapeutic approach. Background:…
  • 2023 International Congress

    Correlates of gait impairment in parkinson’s disease

    E. Abdeldayem, A. Shalash (Cairo, Egypt)

    Objective: Assess gait dysfunction in patients with PD and its correlation with clinical (motor and non-motor symptoms) and radiological findings. Background: Gait impairment is one…
  • 2023 International Congress

    Supra-ON state freezing of gait: The unpredictable response to levodopa in Parkinson´s Disease

    M. Magriço, V. Ferreira, B. Meira, R. Barbosa (Lisboa, Portugal)

    Objective: To discuss the therapeutic dilemma of freezing in supra ON Background: Freezing of gait (FOG) is a common manifestation of Parkinson's disease (PD), occurring…
  • 2023 International Congress

    Palliative Care in Parkinson: a family caregiver’s view. A PD-PAL Consortium initiative.

    D. Trivedi, M. Qamar, V. Leta, M. Meinders, C. Münte, M. Groot, A. Antonini, M. Garon, K. Ray Chaudhuri (London, United Kingdom)

    Objective: We aim to identify clinical indicators and markers for timely referral, access, and need of PC in our PwP community, from the viewpoint of…
  • 2023 International Congress

    The study of genetic factors in levodopa-induced motor complications development in Russian patients with Parkinson’s disease

    G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, S. Umutbaev, R. Galimova, A. Baitimerov, R. Magzhanov (Ufa, Russian Federation)

    Objective: This study is aimed to explore the relationship between the single nucleotide polymorphisms (SNPs) in dopamine and serotonin metabolism genes, other neurotransmitter systems genes…
  • 2023 International Congress

    Correlation between dose of dopamine replacement therapy and King’s Parkinson’s Disease Pain Scale in Mexican Patients with Parkinson’s Disease

    A. Regalado Mustafá, D. Aguila Godinez, A. Herrera Ruiz, E. Santiago-de-La-Cruz, L. Lira Juárez, M. Medrano Delgado, M. Ruiz Mafud, A. Hernández-Medrano, D. Romero-Terán, M. Medina-Pérez, G. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga, G. Hernandez Armesto, A. Abundes-Corona, A. Domínguez García, J. García Hernández, A. Alcocer Salas, K. Talavera Lagunas (Mexico City, Mexico)

    Objective: Investigate the relationship between the dose of dopamine replacement therapy (DRT) and pain severity as measured by the King's Parkinson's Disease Pain Scale (KPPS)…
  • 2023 International Congress

    The effect of APOE ε4 on striatal vesicular monoamine transporter-2 density in Parkinson’s disease

    W. Li, R. Li, J. Lu (Beijing, China)

    Objective: To evaluate the effect of apolipoprotein E 4 (APOE 4) on striatal vesicular monoamine transporter-2 (VMAT2) density in Parkinson’s disease (PD).To evaluate the effect…
  • 2023 International Congress

    Evaluation of neuroprotective role of carvacrol via Nrf2-NLRP3 axis in rotenone induced PD mice model

    D. Khatri, S. Shah, K. Tryphena (Hyderabad, India)

    Objective: To explore the antioxidant and anti-inflammatory role of Carvacrol via Nrf2-NLRP3 axis in rotenone induced PD mice model Background: NLRP3 inflammasome mediated neuroinflammation is…
  • « Previous Page
  • 1
  • …
  • 284
  • 285
  • 286
  • 287
  • 288
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley